WA
CTSO icon

Waverly Advisors’s Cytosorbents Corp CTSO Stock Holding History

Waverly Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.5K Hold
55,556
– – ﹤0.01% 1579
2025
Q4 		$35.5K Hold
55,556
– – ﹤0.01% 1451
2025
Q3 		$51.9K Buy
+55,556
New +$54.7K ﹤0.01% 1272

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Waverly Advisors's CTSO Position: Q1 2026 in Review

Waverly Advisors held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 55,556 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1579.

Waverly Advisors first reported a position in CTSO in Q3 2025 and has held it in 3 quarters since. The position peaked at $51.9K in Q3 2025. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Waverly Advisors held 55,556 shares of Cytosorbents Corp worth $31.5K as of Q1 2026.
  • Waverly Advisors left its Cytosorbents Corp share count unchanged in Q1 2026.
  • Cytosorbents Corp made up ﹤0.01% of Waverly Advisors's portfolio in Q1 2026, its #1579 holding.
  • Waverly Advisors first reported a position in Cytosorbents Corp in Q3 2025 and has held it in 3 quarters since.
  • Waverly Advisors's Cytosorbents Corp position peaked at $51.9K in Q3 2025.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.